Jun 18

APS Type 1 and Immune Tolerance: From Basic Biology to Clinical Translation

The APS Type 1 Foundation, with generous sponsorship by the Clinical Immunology Society and the National Institute of Allergy and Infectious Disease, is honored to host a FOCIS Member Society Symposium at the FOCIS 2024 Annual Meeting. Hosting this half day scientific symposium allows us to showcase our society, research and current initiatives.

Thank you to Drs. Anderson and Lionakis for helping to make this incredible opportunity possible.

Session Chairs
Mihalis Lionakis, MD
National Institute of Allergy and Infectious Diseases

Mark Anderson, MD, PhD
University of California, San Francisco

Session Agenda
Landscape of TEC development and differentiation
Corey Miller, MD, PhD
Assistant Professor, UCSF

TEC differentiation
Matthieu Giraud, PhD
Senior Researcher, Nantes Universite

Dynamics of thymic selection
Ellen Robey, PhD
Professor, UC Berkeley

Human TEC Development
Audrey Parent, PhD
Assistant Professor, UCSF

3:00 PM – 3:30 PM

High throughput screening of APS1 and translation
Joe DeRisi, PhD
Professor, UCSF

Bill Robinson, MD, PhD
Professor, Stanford

Genetics of AIRE-deficiency
Sebastian Ochoa, MD
Assistant Professor, Baylor College of Medicine

Clinical Trial for APS1
Mihalis Lionakis MD, ScD
Senior Investigator, NIAID

For more information, please click here.